Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3Withdrawn 2Active not recruiting 2Unknown 1Suspended 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Hypoxia 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × pimonidazole × Clear all
NCT03262311 2019-12-23

Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours

Institute of Cancer Research, United Kingdom

Phase NA Completed
21 enrolled
Tumor-Agnostic

Neoplasms

NCT01992042 2017-10-26

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
33 enrolled
Genitourinary

Prostatic Neoplasms

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed
14 enrolled
Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡